Form 8-K - Current report:
SEC Accession No. 0001144204-13-048995
Filing Date
2013-09-03
Accepted
2013-09-03 16:30:44
Documents
1
Period of Report
2013-09-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v354270_8k.htm 8-K 13346
  Complete submission text file 0001144204-13-048995.txt   14755
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 131075350
SIC: 2836 Biological Products, (No Diagnostic Substances)